| Line Item | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||
| Revenue | ||||||||||||||||
| YoY growth | -10.0% | -8.2% | -85.4% | -79.9% | ||||||||||||
| Operating Expenses | ||||||||||||||||
| Cost of Revenue | ||||||||||||||||
| Selling, General and Administrative Expense | ||||||||||||||||
| Impairments | — | |||||||||||||||
| Total Operating Expenses | ||||||||||||||||
| % of revenue | 281.4% | 370.4% | 551.0% | 358.2% | ||||||||||||
| Loss from Operations | ||||||||||||||||
| % of revenue | -181.4% | -270.4% | -451.0% | -258.2% | ||||||||||||
| Other (Expense) Income | ||||||||||||||||
| Net Interest Income | — | — | — | — | ||||||||||||
| Interest Expense | ||||||||||||||||
| Non-Operating Income (Expense) | ||||||||||||||||
| Foreign Currency Gain/Loss | ||||||||||||||||
| Income from Equity Method Investments | ||||||||||||||||
| Total Other Expense, Net | ||||||||||||||||
| Net Loss Before Income Taxes | ||||||||||||||||
| Net Loss | ||||||||||||||||
| % of revenue | -591.3% | -535.8% | -2526.7% | 196.6% | ||||||||||||
| Net Income Attributable to Noncontrolling Interest | ||||||||||||||||
| Net Loss Attributable to Common Stockholders | ||||||||||||||||
| % of revenue | -533.4% | -461.1% | -2481.1% | 151.4% | ||||||||||||
| Less Comprehensive (Loss) Income Attributable to Non-controlling Interests | ||||||||||||||||
| Total Comprehensive Loss Attributable to Common Shareholders | ||||||||||||||||
| Earnings Per Share (Basic) | ||||||||||||||||
| Earnings Per Share (Diluted) |